We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.01%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+62.01%
3 Year Est. Return
+164.15%
5 Year Est. Return
+274.12%
10 Year Est. Return
+2,470.02%
AUM
$1.11B
AUM Growth
+$52.8M
Cap. Flow
-$12.7M
Cap. Flow %
-1.14%
Top 10 Hldgs %
19.77%
Holding
2,152
New
581
Increased
526
Reduced
430
Closed
561

Sector Composition

Rank Sector Weight
1 Technology 16.1%
2 Healthcare 13.61%
3 Communication Services 11.16%
4 Consumer Discretionary 6.46%
5 Real Estate 6.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEB icon
1276
Seaboard Corp
SEB
$4.21B
$23K ﹤0.01%
5
-29
-85% -$124K
MGI
1277
PUT
DELISTED
MoneyGram International, Inc. New
MGI
$23K ﹤0.01%
+1,400
New +$22.6K
AVH
1278
DELISTED
AVIANCA HOLDINGS S.A.
AVH
$23K ﹤0.01%
+3,000
New +$22.3K
RXDX
1279
DELISTED
Ignyta, Inc.
RXDX
$23K ﹤0.01%
+1,900
New +$19.6K
ADTN icon
1280
Adtran
ADTN
$710M
$22K ﹤0.01%
+900
New +$19.9K
COKE icon
1281
Coca-Cola Consolidated
COKE
$12B
$22K ﹤0.01%
+1,000
New +$22.1K
GNRC icon
1282
Generac Holdings
GNRC
$12.9B
$22K ﹤0.01%
+476
New +$18.7K
GOOD
1283
Gladstone Commercial Corp
GOOD
$604M
$22K ﹤0.01%
+1,000
New +$21.3K
ICFI icon
1284
ICF International
ICFI
$1.56B
$22K ﹤0.01%
400
-1,500
-79% -$70.9K
ODFL icon
1285
PUT
Old Dominion Freight Line
ODFL
$44B
$22K ﹤0.01%
+600
New +$19.8K
SHOO icon
1286
Steven Madden
SHOO
$3.49B
$22K ﹤0.01%
750
-8,273
-92% -$228K
CSCI
1287
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$22K ﹤0.01%
107
+97
+970% +$17.9K
CCF
1288
DELISTED
Chase Corporation
CCF
$22K ﹤0.01%
200
-117
-37% -$11.9K
ZIXI
1289
DELISTED
Zix Corporation
ZIXI
$22K ﹤0.01%
+4,400
New +$23.2K
HRC
1290
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$22K ﹤0.01%
+300
New +$23.1K
AKS
1291
DELISTED
AK Steel Holding Corp
AKS
$22K ﹤0.01%
3,900
-28,700
-88% -$164K
HZNP
1292
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$22K ﹤0.01%
+1,700
New +$21.6K
PGEM
1293
DELISTED
Ply Gem Holdings, Inc.
PGEM
$22K ﹤0.01%
+1,300
New +$21.4K
ABUS icon
1294
Arbutus Biopharma
ABUS
$861M
$21K ﹤0.01%
+3,400
New +$14.5K
BCC icon
1295
Boise Cascade
BCC
$2.92B
$21K ﹤0.01%
600
+100
+20% +$3.04K
DXJ icon
1296
WisdomTree Japan Hedged Equity Fund
DXJ
$7.2B
$21K ﹤0.01%
384
-1,223
-76% -$64.2K
LXU icon
1297
LSB Industries
LXU
$707M
$21K ﹤0.01%
+3,380
New +$20.2K
SSP icon
1298
E.W. Scripps
SSP
$258M
$21K ﹤0.01%
+1,100
New +$20.2K
VSTM icon
1299
Verastem
VSTM
$500M
$21K ﹤0.01%
375
+125
+50% +$5.9K
CLUB
1300
DELISTED
Town Sports International Holdings, Inc.
CLUB
$21K ﹤0.01%
2,951
-3,916
-57% -$21.9K

Similar funds

Prelude Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Prelude Capital Management held 2,152 positions worth $1.11B, up 5% from $1.06B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Prelude Capital Management's Q3 2017 filing shows 581 new, 526 increased, 430 reduced and 561 closed positions. Its largest new stake was Rockwell Collins: 63,879 shares worth $8.35M. The largest sale was Mobileye N.V., an estimated $25.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Communication Services.

  • Prelude Capital Management's largest Q3 2017 buy was Rockwell Collins: 63,879 shares worth $8.35M.
  • Prelude Capital Management added most to Calpine Corporation in Q3 2017, an estimated $12.6M increase.
  • Prelude Capital Management's biggest Q3 2017 reduction was Gray Television, cutting an estimated $14.3M.
  • Prelude Capital Management fully exited Mobileye N.V. in Q3 2017, selling an estimated $25.8M.
  • Prelude Capital Management's ten largest holdings make up 20% of its $1.11B portfolio in Q3 2017.
  • Prelude Capital Management opened 581 new positions and closed 561 in Q3 2017.
  • Prelude Capital Management's portfolio value rose 5% quarter-over-quarter to $1.11B.

Based on Prelude Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.